Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000912057-17-000010
Filing Date
2017-01-19
Accepted
2017-01-19 07:26:58
Documents
13

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2063490
2 filename2.htm EX-21.1 1443
3 g178708.jpg GRAPHIC 65596
4 g194287.jpg GRAPHIC 206420
5 g248340.jpg GRAPHIC 54773
6 g256830.jpg GRAPHIC 81517
7 g454073.jpg GRAPHIC 27830
8 g533242.jpg GRAPHIC 103362
9 g668517.jpg GRAPHIC 186127
10 g700374.jpg GRAPHIC 73675
11 g766537.jpg GRAPHIC 76983
12 g799768.jpg GRAPHIC 83640
13 g823840.jpg GRAPHIC 15173
  Complete submission text file 0000912057-17-000010.txt   3410230
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

EIN.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01321 | Film No.: 17534821
SIC: 2834 Pharmaceutical Preparations